{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T03:42:37Z","timestamp":1771645357213,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.yebeh.2021.108190","type":"journal-article","created":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T19:48:18Z","timestamp":1626292098000},"page":"108190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Longitudinal impact of cannabidiol on EEG measures in subjects with treatment-resistant epilepsy"],"prefix":"10.1016","volume":"122","author":[{"given":"Leslie","family":"Grayson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Ampah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Hernando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1880-5563","authenticated-orcid":false,"given":"Pongkiat","family":"Kankirawatana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyler","family":"Gaston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Cutter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerzy P.","family":"Szaflarski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Martina Bebin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2021.108190_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jep.2006.02.001","article-title":"Cannabinoids in medicine: a review of their therapeutic potential","volume":"105","author":"Ben Amar","year":"2006","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.yebeh.2021.108190_b0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.expneurol.2011.11.047","article-title":"Marijuana, endocannabinoids, and epilepsy: Potential and challenges for improved therapeutic intervention","volume":"244","author":"Hofmann","year":"2013","journal-title":"Exp Neurol"},{"key":"10.1016\/j.yebeh.2021.108190_b0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1124\/jpet.103.051920","article-title":"The Endogenous cannabinoid system regulates seizure frequency and duration i na model of temporal lobe epilepsy","volume":"307","author":"Wallace","year":"2003","journal-title":"J Pharmacol Exp Therap"},{"key":"10.1016\/j.yebeh.2021.108190_b0020","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0014-2999(01)01243-2","article-title":"Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects","volume":"428","author":"Wallace","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.yebeh.2021.108190_b0025","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0022-3565(25)30824-4","article-title":"Cannabidiol-antiepiletic drug comparisons and interactions in experimentally induced seizures in rats","volume":"201","author":"Consroe","year":"1977","journal-title":"J Pharmacol Exp Therap"},{"key":"10.1016\/j.yebeh.2021.108190_b0030","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.seizure.2012.03.001","article-title":"Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures","volume":"21","author":"Jones","year":"2012","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2021.108190_b0035","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1124\/jpet.109.159145","article-title":"Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo","volume":"332","author":"Jones","year":"2010","journal-title":"J Pharmacol Exp Therap"},{"key":"10.1016\/j.yebeh.2021.108190_b0040","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.92.15_supplement.P5.5-007","article-title":"The proposed multimodal mechanism of action of cannabidiol (CBD) in epilepsy: modulation of intracellular calcium and adenosine-mediated signaling (P5.5-007)","volume":"92","author":"Nichol","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2021.108190_b0045","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11910-018-0882-y","article-title":"Cannabis for the treatment of epilepsy: an update","volume":"18","author":"Gaston","year":"2018","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.yebeh.2021.108190_b0050","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/epi.12631","article-title":"Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders","volume":"55","author":"Devinsky","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2021.108190_b0055","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1001\/jamaneurol.2018.3550","article-title":"The US Food and Drug Administration\u2019s authorization of the first cannabis-derived pharmaceutical: are we out of the haze?","volume":"76","author":"Yang","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.yebeh.2021.108190_b0060","doi-asserted-by":"crossref","first-page":"ii2","DOI":"10.1136\/jnnp.2005.069245","article-title":"EEG in the diagnosis, classification, and management of patients with epilepsy","volume":"76","author":"Smith","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.yebeh.2021.108190_b0065","series-title":"The Epilepsies: Seizures, Syndromes and Management","article-title":"Optimal use of the EEG in the diagnosis and management of epilepsies","author":"Cp","year":"2005"},{"key":"10.1016\/j.yebeh.2021.108190_b0070","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/adc.73.6.557","article-title":"The place of the EEG and imaging in the management of seizures","volume":"73","author":"Verity","year":"1995","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.yebeh.2021.108190_b0075","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/bmj.332.7537.339","article-title":"The first seizure and its management in adults and children","volume":"332","author":"Pohlmann-Eden","year":"2006","journal-title":"BMJ Br Med J"},{"key":"10.1016\/j.yebeh.2021.108190_b0080","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1528-1167.2006.00654.x","article-title":"Interictal EEG and the diagnosis of epilepsy","volume":"47","author":"Pillai","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2021.108190_b0085","doi-asserted-by":"crossref","unstructured":"Jerzy P. Szaflarski, Anne M. Comi, Anup D. Patel, Charuta Joshi Daniel Checketts Jules C. Beal Linda C. Laux Lisa M. De Boer Matthew H. Wong Merrick Lopez Orrin Devinsky Paul D. Lyons Pilar Pichon Zentil Robert Wechsler on behalf of CBD EAP study group. Long\u2010term safety and treatment effects of cannabidiol in children and adults with treatment\u2010resistant epilepsies: Expanded access program results. Epilepsia 2018;59: 1540-1548.","DOI":"10.1111\/epi.14477"},{"key":"10.1016\/j.yebeh.2021.108190_b0090","series-title":"Electroencephalography (EEG): an introductory text and atlas of normal and abnormal findings in adults, children and infants","author":"Britton","year":"2016"},{"key":"10.1016\/j.yebeh.2021.108190_b0095","unstructured":"Britton JW, Frey LC, Hopp JL, Korb P, Koubeissi MZ, Lievens WE, et al.,. The Abnormal EEG. In: St. Louis EK FL, editor. Electroencephalography (EEG): An Introductory Text and Atlas of Normal and Abnormal Findings in Adults, Children, and Infants. Chicago: American Epilepsy Society; 2016."},{"key":"10.1016\/j.yebeh.2021.108190_b0100","unstructured":"Hirsch LJ, LaRoche S, Gaspard N, Gerard E, Sovoronos A, Herman S, et al., American Clinical Neurophysiology Society's Standardized Critical Care EEG Terminology: 2012 Version. In. ACNS; 2012."},{"key":"10.1016\/j.yebeh.2021.108190_b0105","doi-asserted-by":"crossref","unstructured":"Jerzy P. Szaflarski, Gary Cutterd, Jennifer DeWolfe, Leon S. Dure, Tyler E. Gaston, Pongkiat Kankirawatan, Yuliang Liu, Rani Singh, David G. Standaert, Ashley E. Thomas, Lawrence W. Ver Hoef for the UAB CBD Program. Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study. Epilepsy Behavior 2018;87: 131-136.","DOI":"10.1016\/j.yebeh.2018.07.020"},{"key":"10.1016\/j.yebeh.2021.108190_b0110","doi-asserted-by":"crossref","unstructured":"Blathnaid McCoy LW, Maria Zak, Sameer Al-Mehmadi, Nadia Kabir, Kenda Alhadid, Kyla McDonald, et al., A prospective open-label trial of a CBD\/THC cannabis oil in dravet syndrome. Ann Clin Transl Neurol 2018;5: 1077-1088.","DOI":"10.1002\/acn3.621"},{"key":"10.1016\/j.yebeh.2021.108190_b0115","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/0883073816669450","article-title":"Cannabidiol as a potential treatment for febrile infection-related epilepsy syndrome (FIRES) in the acute and chronic phases","volume":"32","author":"Gofshteyn","year":"2017","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2021.108190_b0120","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/00207459309000566","article-title":"Effect of carbamazepine on EEG background activity and on interictal epileptiform abnormalities in focal epilepsy","volume":"70","author":"Marciani","year":"1993","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.yebeh.2021.108190_b0125","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1365-2125.1983.tb02163.x","article-title":"Acute effects of intravenous phenytoin on the frequency of inter-ictal spikes in man","volume":"16","author":"Milligan","year":"1983","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.yebeh.2021.108190_b0130","doi-asserted-by":"crossref","unstructured":"Libenson MH, Caravale B. Do antiepileptic drugs differ in suppressing interictal epileptiform activity in children? Pediatric Neurol 24: 214-218.","DOI":"10.1016\/S0887-8994(00)00271-X"},{"key":"10.1016\/j.yebeh.2021.108190_b0135","doi-asserted-by":"crossref","unstructured":"Rocamora R, Wagner K, Schulze-Bonhage A. Levetiracetam reduces frequency and duration of epileptic activity in patients with refractory primary generalized epilepsy. Seizure 15: 428-433.","DOI":"10.1016\/j.seizure.2006.05.012"},{"key":"10.1016\/j.yebeh.2021.108190_b0140","first-page":"453","article-title":"The influence of antiepileptic drugs on the electroencephalogram: a review of controlled clinical studies","volume":"36","author":"Schmidt","year":"1982","journal-title":"Electroencephalogr Clin Neurophysiol Suppl"},{"key":"10.1016\/j.yebeh.2021.108190_b0145","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1528-1157.1988.tb03768.x","article-title":"The role of the EEG in epilepsy of long duration","volume":"29","author":"Desai","year":"1998","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2021.108190_b0150","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1684\/j.1950-6945.2005.tb00139.x","article-title":"Spike frequency is dependent on epilepsy duration and seizure frequency in temporal lobe epilepsy","volume":"7","author":"Jozsef Janszky","year":"2005","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2021.108190_b0155","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/0013-4694(90)90114-Y","article-title":"Factors affecting interictal spike discharges in adults with epilepsy","volume":"75","author":"Sundaram","year":"1990","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1016\/j.yebeh.2021.108190_b0160","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1212\/01.WNL.0000058761.12715.0E","article-title":"Intractable temporal lobe epilepsy with rare spikes is less severe than with frequent spikes","volume":"60","author":"Rosati","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2021.108190_b0165","doi-asserted-by":"crossref","unstructured":"Megan F, Selvitelli M, Walker LM, Schomer DL, Chang BS, The relationship of interictal epileptiform discharges to clinical epilepsy severity: a study of routine EEGs and review of the literature. J Clin Neurophysiol 2010;27: 87-92.","DOI":"10.1097\/WNP.0b013e3181d64b1e"},{"key":"10.1016\/j.yebeh.2021.108190_b0170","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11910-018-0892-9","article-title":"The impact of interictal discharges on performance","volume":"18","author":"Faught","year":"2018","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.yebeh.2021.108190_b0175","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s12883-020-01807-z","article-title":"The effect of interictal epileptiform discharges on cognitive and academic performance in children with idiopathic epilepsy","volume":"20","author":"Cheng","year":"2020","journal-title":"BMC Neurol"},{"key":"10.1016\/j.yebeh.2021.108190_b0180","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ejpn.2012.05.010","article-title":"Cognitive effects of interictal epileptiform discharges in children","volume":"16","author":"Ebus","year":"2012","journal-title":"Eur J Paediat Neurol"},{"key":"10.1016\/j.yebeh.2021.108190_b0185","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.yebeh.2013.07.014","article-title":"Cognitive correlates of interictal epileptiform discharges in adult patients with epilepsy in China","volume":"29","author":"Lv","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2021.108190_b0190","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.yebeh.2015.01.041","article-title":"Cognitive and behavioral outcomes in benign childhood epilepsy with centrotemporal spikes","volume":"45","author":"Vannest","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2021.108190_b0195","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1212\/WNL.0000000000002592","article-title":"Routine vs extended outpatient EEG for the detection of interictal epileptiform discharges","volume":"86","author":"Burkholder","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2021.108190_b0200","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.0013-9580.2004.51003.x","article-title":"Evaluating the utility of inpatient video-EEG monitoring","volume":"45","author":"Ghougassian","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2021.108190_b0205","doi-asserted-by":"crossref","unstructured":"Friedman DE HL. How long does it take to make an accurate diagnosis in an epilepsy monitoring unit? J Clin Neurophysiol 2009;26.","DOI":"10.1097\/WNP.0b013e3181b2f2da"},{"key":"10.1016\/j.yebeh.2021.108190_b0210","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1046\/j.1528-1157.2003.60602.x","article-title":"Assessment of CNS effects of antiepileptic drugs by using quantitative EEG measures","volume":"44","author":"Salinsky","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2021.108190_b0215","doi-asserted-by":"crossref","unstructured":"Salinsky MC, Spencer DC, Oken BS, Storzbach D. Effects of oxcarbazepine and phenytoin on the EEG and cognition in healthy volunteers. Epilepsy Behav 5: 894-902.","DOI":"10.1016\/j.yebeh.2004.07.011"},{"key":"10.1016\/j.yebeh.2021.108190_b0220","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.yebeh.2019.04.044","article-title":"Cognitive functioning following long-term cannabidiol use in adults with treatment-resistant epilepsy","volume":"97","author":"Martin","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2021.108190_b0225","doi-asserted-by":"crossref","first-page":"107299","DOI":"10.1016\/j.yebeh.2020.107299","article-title":"Cognitive function and adaptive skills after a one-year trial of cannabidiol (CBD) in a pediatric sample with treatment-resistant epilepsy","volume":"111","author":"Thompson","year":"2020","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2021.108190_b0230","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.yebeh.2010.06.033","article-title":"The postictal EEG","volume":"19","author":"So","year":"2010","journal-title":"Epilepsy Behav"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505021004510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505021004510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:41:07Z","timestamp":1761504067000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505021004510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":46,"alternative-id":["S1525505021004510"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2021.108190","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal impact of cannabidiol on EEG measures in subjects with treatment-resistant epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2021.108190","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108190"}}